Recent News

rss

Important Information

from the State Medical Board of Ohio

June Issue of eNews Published

The June 2018 issue of the Medical Board's eNews has arrived. Here are the highlights:

  • Supervision Agreement Changes

  • Upcoming License Renewal Deadlines

  • Policy Statement for Massage Therapists

  • Proposed Rules

  • Out-of-State License Verifications

  • Prescriber Resources

  • MMCP FAQs

  • Certificates to Recommend

  • NTSB Safety Recommendation

  • Harmful Algal Blooms

  • Free CME and Continuing Education Webinar

Click here for all of the details.

 

Holiday Closure

In observance of Independence Day, our office will be closed tomorrow, July 4th. We will resume normal business hours on Thursday at 8 a.m.

 

 

Board Seeks Comment on Two Proposed Rules

The Medical Board is seeking comments on the initial review of two rules. The proposed language for each rule can be found by clicking on the links below.

Comments on the rules should be submitted to Sallie Debolt, Senior Counsel, State Medical Board of Ohio at Sallie.Debolt@med.ohio.gov by July 9th. 

 

Massage Therapy Curriculum Requirements

Scope of Practice: Massage Therapy

 

National Transportation Safety Board's Safety Recommendations for Health Care Providers

The National Transportation Safety Board (NTSB) is asking health care providers across the country to counsel their patients regarding the effect medication use may have on their ability to safely operate a vehicle.

 

The use of over-the-counter (OTC), prescription, and illicit drugs is increasing in the US population. The NTSB is concerned about the possible safety implications of increased drug use in all modes of transportation, but data about drug use by vehicle operators is limited to a small proportion of operators and a short list of drugs. Therefore, NTSB did a study of airline pilots and accidents- a mode of transportation where there was a substantial data set available. The findings of that study prompted the NTSB to reach out to prescribers across the country.

 

NTSB urges prescribers to highlight the importance of routinely discussing with patients the effect their diagnosed medical conditions or recommended drugs may have on their ability to safely operate a vehicle in any mode of transportation.

 

In addition, the NTSB has asked regulatory boards to incorporate reminders about these important discussions with patients in prescribing guidelines. The State Medical Board of Ohio’s resolution was adopted on June 13, 2018:

 

Resolution: Guideline for Patient Discussion Regarding Vehicle Operation When Prescribing Controlled Substances for Pain

Adopted June 13, 2018

The Board hereby makes the following recommendation to our licensed health care providers when prescribing controlled substances for pain. It is recommended that the prescribers licensed by the Board inform the patient of the effect the patient’s medication may have on the patient’s ability to safely operate a vehicle. This recommendation is consistent with the National Transportation Safety Board Safety Recommendation, I-14-1 and I-14-2.

 

NTSB an independent federal agency charged by Congress with investigating every civil aviation accident in the United States and significant accidents in other modes of transportation to determine the probable cause of the accidents. In consideration of investigative findings, the NTSB issues safety recommendations aimed at preventing future accidents and saving lives.

 

Click here for a link to the resolution.

 

Maker of Naloxone Issues Voluntary Recall For Some Syringe Systems

The opioid overdose antidote Naloxone has been voluntarily recalled by its maker, Hospira. It was prompted by the potential for the presence of embedded and loose particulate matter on the syringe plunger. The recall affects the hospital/institution level according to the announcement made by the FDA.

 

The affected lots are: 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). Only the injectable type is affected by this recall.

 

More information can be found on the U.S. Food & Drug Administration’s website: https://www.fda.gov/safety/recalls/ucm609668.htm

The May Issue of eNews Published

The May 2018 issue of the Medical Board's eNews has arrived. Here are the highlights:

  • ICD-10 Required on All Controlled Substance Rx

  • Rules Effective May 31, 2018

  • OARRS Prescriber Practice Reports

  • New Board Member Appointed

  • Medical Marijuana FAQs

  • Take Charge Ohio PSA

  • CE Broker Partnership

  • CME for Volunteer Services

Click here for all of the details.

Specify Alternate Text

HealthScene Ohio Spring 2018 Issue Online

HealthScene Ohio, the Medical Board’s quarterly magazine, is now available. The spring 2018 issue features articles about temporary blindness and recovery, foot care, a state-wide initiative to prevent falls, exercise and Parkinson's, deep brain stimulation, a physician's success honors his family, preventing GERD, practicing in both Columbus and Cameroon, laser treatment for epilepsy, preventing illness, addiction and death and reporting injuries that result from a crime.

 

Public Hearing for Proposed New Rules

A public hearing on proposed rules will be held on July 9, 2018, at 1:30 p.m. in the Lobby Hearing Room, Rhodes State Office Tower, 30 E. Broad Street, 1st Floor, Columbus, OH 43215. Oral and written testimony may be presented by any person affected by the proposed rules.

 

Notice of July 9, 2018 Public Hearing

 

Proposed Rules

4731-28-02 Eligibility for confidential monitoring program

4731-28-03 Participation in the confidential monitoring program

4731-28-04 Disqualification from continued participation in the confidential monitoring program

4731-28-05 Termination of the participation agreement for the confidential monitoring program

 

Board Seeks Comment Regarding One-bite Program

The State Medical Board of Ohio has filed proposed actions concerning rules with the Common Sense Initiative Office. The proposals are available for your comment.

 

Section 4731.251, Ohio Revised Code, requires the Medical Board to adopt rules that establish a program by which all Medical Board licensees may receive confidential treatment for impairment by drugs, alcohol or other substances of abuse.

Rule 4731-16-17: sets forth the requirements of the one-bite program.

Rule 4731-16-18: sets forth the eligibility criteria for program participants.

Rule 4731-16-19: sets forth the requirements for the monitoring organization.

Rule 4731-16-20: sets forth the requirements for the treatment providers.

Rule 4731-16-21: sets forth the requirements for continuing care.

 

Please provide comments to both of the following:

Comment deadline: June 15, 2018

 

Track Your CE/CME Online With CE Broker

The State Medical Board of Ohio (SMBO) has partnered with CE Broker to simplify your CE/CME tracking and reporting. Using CE Broker Basic, you can track your course completion and report hours free of charge. There is no requirement that licensees sign up for any CE Broker account at this time. It is an optional tool that is being offered.

 

MDs, DOs, DPMs, CTs, GCs, RCPs and LDs – you can use your free CE Broker account to:

  • See what courses you have completed

  • Find board-verified courses

  • Report your CE/CME

  • Learn when you have completed all requirements

  • Contact CE Broker support for help

 

To create your free CE Broker Basic account:

1.     Click here.

2.     Choose from the account options. The free account option is called Basic.

3.     Enter your license number and answer a few easy questions.

 

CE Broker offers additional account options including a Professional Account and a Concierge Account. SMBO licensees are welcome to sign up for these services if interested.

 

Note, entering your continuing education through CE Broker will not automatically renew your license. You will still need to file a license renewal through the eLicense portal. CE Broker allows the Board to verify your completed continuing education following your renewal.

 

SMBO randomly audits a percentage of practitioners CE/CME compliance during each renewal cycle. If you are selected for audit, you will be requested to respond to the audit via CE Broker.

 

To learn more, view a brief introductory video: https://vimeo.com/285009321

 

CE Broker has a full-time support center open Monday – Friday, 8 a.m. – 8 p.m. EST to assist you with questions. You can reach them at www.cebroker.com, (877) 434-6323 or support@cebroker.com.